Does PENTOSTATIN Cause Off label use? 32 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Off label use have been filed in association with PENTOSTATIN (Nipent). This represents 7.0% of all adverse event reports for PENTOSTATIN.
32
Reports of Off label use with PENTOSTATIN
7.0%
of all PENTOSTATIN reports
11
Deaths
4
Hospitalizations
How Dangerous Is Off label use From PENTOSTATIN?
Of the 32 reports, 11 (34.4%) resulted in death, 4 (12.5%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PENTOSTATIN. However, 32 reports have been filed with the FAERS database.
What Other Side Effects Does PENTOSTATIN Cause?
Neutropenia (42)
Drug ineffective (37)
Bk virus infection (30)
Anaemia (28)
Dyspnoea (24)
Pyrexia (24)
Thrombocytopenia (24)
Cystitis haemorrhagic (23)
Product use in unapproved indication (23)
Sepsis (23)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which PENTOSTATIN Alternatives Have Lower Off label use Risk?
PENTOSTATIN vs PENTOXIFYLLINE
PENTOSTATIN vs PERAMIVIR
PENTOSTATIN vs PERAMPANEL
PENTOSTATIN vs PERAZINE
PENTOSTATIN vs PERCOCET